Stocks in play: Oncolytics Biotech Inc

Announces the publication of two abstracts for poster presentations at the upcoming San Antonio Breast Cancer Symposium, to be held at the Henry B. González Convention Center in San Antonio, Texas from December 6 – 10, 2022. One will feature interim results from a bridging clinical trial being conducted by Oncolytics' partner, Adlai Nortye, to evaluate pelareorep-paclitaxel combination therapy in Chinese patients with advanced or metastatic HR+/HER2- breast cancer. The second poster, in collaboration with SOLTI-Innovative Cancer Research, will include data from the AWARE-1 window-of-opportunity study in early-stage breast cancer patients. Oncolytics Biotech Inc shares T.ONC are trading -$0.11 at $1.88.

Read: